Mahinay, Joella Mae S.
HRN: 18-62-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2023
METRONIDAZOLE 500MG (TAB)
10/23/2023
10/31/2023
PO
1 Tab
TID
SP NSVD: MSAF THICKLY
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes